Niek Sanders received his M.S. in 1997, and his Ph.D. degree in 2001, in pharmaceutical sciences. During his Ph.D. degree, he studied the barrier properties of cystic fibrosis (CF) lung mucus towards CF gene therapy. His Ph.D. degree work was awarded with the Leonardo Award (Pharmacia-Pfizer) and the National Price of the Belgian Society of Pharmaceutical Sciences. Since 2002, he worked as a Postdoctoral Fellow of the National Fund for Scientific Research (FWO), at Ghent University, Belgium, at the Ludwig-Maximilians-Universität, Mü nchen, Munich, Germany, and at the University of Utrecht, Utrecht, The Netherlands. The main focus of his postdoctoral research was the development and in vitro evaluation of new delivery systems for DNA and siRNA. In 2008 he became Research Professor in gene therapy at Ghent University, and established there a new research group that focuses on genetic vaccination, cancer vaccination, and targeted delivery of chemotherapeutics. He is considered to be an expert at gene delivery, gene-based vaccines, cancer vaccination, vivo optical imaging, and targeted drug delivery.
Biography Updated on 18 September 2012